Table 1 Comparison of clinical data among the IVIG-responsive and IVIG-resistant groups in KD.
Variables | Total (n = 438) | IVIG-response (n = 398) | IVIG-resistance (n = 40) | p |
|---|---|---|---|---|
Male, n (%) | 271 (61.87) | 249 (62.56) | 22 (55.00) | 0.348 |
Age (months) | 24.00 (13.00, 42.00) | 24.00 (13.00, 43.00) | 29.00 (12.00, 37.00) | 0.752 |
Days of pre-IVIG fever | 6 (5–7) | 6 (5–7) | 6 (5–8) | 0.083 |
WBC (109/L) | 13.92 (10.77, 17.26) | 13.97 (10.95, 17.18) | 13.35 (10.14, 17.77) | 0.671 |
NP (%) | 65.5 (52.19, 76.78) | 65.26 (51.62, 76.06) | 73.77 (60, 34, 82.56) | 0.029 |
Hb (g/L) | 105.00 (96.00, 113.00) | 106.00 (97.00, 114.00) | 96.00 (89.00, 103.00) | < 0.001 |
PLT (109/L) | 349.00 (267.00, 446.00) | 358.00 (279.00, 444.00) | 306.00 (216.00, 524.00) | 0.26 |
AST (U/L) | 33.00 (26.00, 51.00) | 33.00 (26.00, 49.00) | 43.00 (31.00, 53.00) | 0.083 |
ALT (U/L) | 27.00 (16.00, 70.00) | 27.00 (16.00, 70.00) | 27.00 (18.00, 68.00) | 0.927 |
Total bilirubin (μmoL/L) | 5.90 (4.00, 8.60) | 5.90 (4.00, 8.60) | 6.50 (4.700, 10.60) | 0.186 |
ALB (g/L) | 37.65 (33.89, 41.03) | 37.65 (34.50, 41.07) | 33.24 (29.28, 37.65) | < 0.001 |
CRP (mg/L) | 74.71 (42.50, 128.32) | 74.71 (41.03, 126.50) | 97.60 (52.93, 151.78) | 0.122 |
ESR (mm/h) | 59.50 (46.00, 79.00) | 59.50 (46.00, 78.00) | 59.50 (45.00, 81.00) | 0.531 |
Sodium (mmol/L) | 136.90 (135.40, 138.20) | 136.90 (135.70, 138.40) | 136.00 (134.20, 136.90) | 0.003 |
Incomplete KD, n (%) | 83 (18.95) | 75 (18.84) | 8 (20.00) | 0.859 |
CALs, n (%) | 79 (18%) | 68 (17.1%) | 11 (27.5%) | < 0.001 |
NPAR | 1.72 (1.33, 2.12) | 1.70 (1.32, 2.09) | 2.11 (1.62, 2.63) | < 0.001 |
